Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

OptimizeRx Corporation Common Stock (OPRX)

Services-business Services, Nec

https://www.optimizerx.com

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

260 CHARLES STREET, SUITE 302
WALTHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2009

Market Cap

154,562,508

Shares Outstanding

18,150,000

Weighted SO

18,152,478

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

FORA --.--%

STRM --.--%

ACON --.--%

HSTM --.--%

MDRX --.--%

NRC --.--%

CPSI --.--%

DH --.--%

NXGN --.--%

Beta

1.2640

Last Div

0.0000

Range

6.92-16.65

Chg

0.0600

Avg Vol

126274

Mkt Cap

154562508

Exch

NASDAQ

Country

US

Phone

248 651 6568

DCF Diff

21.7681

DCF

-10.8581

Div Yield

0.0000

P/S

1.8577

EV Multiple

-10.3774

P/FV

1.2764

Div Yield %

0.0000

P/E

-8.6225

PEG

-0.2574

Payout

0.0000

Current Ratio

3.0736

Quick Ratio

3.0736

Cash Ratio

1.0002

DSO

115.6516

DIO

0.0000

Op Cycle

115.6516

DPO

32.1873

CCC

83.4643

Gross Margin

0.5938

Op Margin

-0.2793

Pretax Margin

-0.3156

Net Margin

-0.2153

Eff Tax Rate

0.3177

ROA

-0.1036

ROE

-0.1474

ROCE

-0.1471

NI/EBT

0.6823

EBT/EBIT

1.1301

EBIT/Rev

-0.2793

Debt Ratio

0.2072

D/E

0.2960

LT Debt/Cap

0.2107

Total Debt/Cap

0.2284

Int Coverage

0.0295

CF/Debt

-0.0526

Equity Multi

1.4285

Rec Turnover

3.1560

Pay Turnover

11.3399

Inv Turnover

0.0000

FA Turnover

129.3972

Asset Turnover

0.4813

OCF/Share

-0.1032

FCF/Share

-0.0914

Cash/Share

0.8193

OCF/Sales

-0.0227

FCF/OCF

0.8857

CF Coverage

-0.0526

ST Coverage

-0.5356

CapEx Coverage

-8.7516

Div&CapEx Cov

-8.7516

P/BV

1.2764

P/B

1.2764

P/S

1.8577

P/E

-8.6225

P/FCF

-92.5905

P/OCF

-81.9571

P/CF

-81.9571

PEG

-0.2574

P/S

1.8577

EV Multiple

-10.3774

P/FV

1.2764

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Aug 01, 22:30 Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates GlobeNewswire Inc. Jan 09, 07:30 OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update GlobeNewswire Inc. Dec 18, 07:30 OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco Zacks Investment Research Nov 23, 05:35 3 Stocks Worth a Buy for Superb Earnings Acceleration GlobeNewswire Inc. Oct 25, 07:30 OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET

Revenue Product Segmentation